- Conduit Pharmaceuticals to Join Russell 3000® Index
- Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
- Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
- Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
- Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.8548 |
---|---|
High | 0.90 |
Low | 0.63 |
Bid | 0.70 |
Offer | 0.80 |
Previous close | 0.8793 |
Average volume | 399.59k |
---|---|
Shares outstanding | 73.83m |
Free float | 9.85m |
P/E (TTM) | -- |
Market cap | 47.26m USD |
EPS (TTM) | -0.0339 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
More ▼